[Bankruptcy] Hospital Director’s Sudden Death Leads “Ita-no-kai,” Operator of Kurume Chuo Hospital, to File for Bankruptcy with 1.245 Billion Yen in Debt Amidst Declining Performance During the COVID

News Highlights

It has been revealed that “Ita-no-kai,” a medical corporation operating Kurume Chuo Hospital in Kurume City, Fukuoka Prefecture, filed for bankruptcy on April 1, 2026. The total debt amounts to approximately 1.245 billion yen. The cause is believed to be the sudden death of the hospital’s director, compounded by declining performance during the COVID-19 pandemic, which strained management. This situation raises concerns about the impact on regional healthcare.

M&A Medical Editorial Department’s Perspective

The bankruptcy of “Ita-no-kai,” the operator of Kurume Chuo Hospital, highlights the devastating impact that an unforeseeable risk like the “sudden death of the hospital director” can have when combined with external factors such as the COVID-19 pandemic. The scale of the debt, 1.245 billion yen, suggests a situation beyond mere financial difficulty, indicating the impossibility of continuing operations. In particular, the fact that the director’s personal sudden death directly led to the corporation’s bankruptcy forces us to reconsider the governance structure of medical corporations and the extent of personal joint guarantees and debt burdens undertaken by directors. While many medical institutions experienced declining performance during the pandemic, in this case, it proved to be the decisive blow. Coupled with the structural issue of a lack of successors, it is highly probable that opportunities for business succession through M&A were lost. This case suggests that early consultation regarding business succession was the only way to avoid such a worst-case scenario.

Points Raised by This News

• Structural issues of governance and debt burden where the sudden death of the director directly led to corporate bankruptcy.
• The lethality when declining performance during the COVID-19 pandemic overlaps with the unforeseeable risk of the director’s sudden death.
• The serious financial situation indicated by the debt of 1.245 billion yen, leading to the abandonment of business continuity.
• The unavoidable reality of the risk of a healthcare void in the region and the impact on patients and staff.

Practical Questions Arising from This News

• How are the director’s personal joint guarantees and debts handled in the event of corporate bankruptcy?
• In the event of a sudden death, how can the business continuity and M&A of a medical corporation proceed?
• What measures should medical institutions whose performance has deteriorated due to the COVID-19 pandemic take?

If You Feel “Should I Consult Too?”

If your institution is also experiencing concerns about the aging of the director, health issues, or declining performance since the COVID-19 pandemic, the case of Kurume Chuo Hospital is not an isolated incident. Business succession and M&A are effective means to maximize options and achieve a smooth handover before any unforeseen events occur. Let’s start by consulting with experts to explore your institution’s current situation and future possibilities.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics on a full success fee basis as an M&A support institution certified by the Small and Medium Enterprise Agency. We handle consultations with strict confidentiality. Free consultations are available here.